The cGAS-STING pathway, crucial for innate immunity, drives harmful neuroinflammation in aging and Alzheimer’s, with recent studies highlighting therapeutic challenges and biomarker potential fo...
An analysis of clonal hematopoiesis, a somatic mosaicism in blood cells linked to aging, cancer, and cardiovascular risks, exploring ethical challenges in screening. Recent studies highlight clonal he...
Recent studies validate blood biomarkers like p-tau217 for predicting Alzheimer’s onset within 3-4 years at 94% accuracy, enabling early interventions but raising ethical and socioeconomic conce...
Recent ethical debates in longevity science highlight public support for life extension with equity, expert calls for transparency, and policy integration to address ageism and access disparities. Adv...
Recent research shows targeted removal of dysfunctional B cells in aged mice improves immune function and healthspan, suggesting new therapeutic avenues for combating age-related decline. A new study ...
New research on position effect variegation in Drosophila reveals epigenetic aging markers, linking heterochromatin stability to longevity and informing anti-aging therapies. Recent studies show PEV i...
Recent studies show mTOR inhibitors like rapamycin reduce DNA damage and senescence in immune cells, offering a new approach to enhance healthy aging and combat age-related immune decline. New researc...
Recent research reveals ferroptosis, an iron-dependent cell death mechanism, as a key factor in age-related muscle loss, with potential therapies targeting lipid peroxidation. A 2023 study in ‘A...
Recent studies reveal transcription factors AP1 and KLF5 drive T cell senescence, with new epigenetic interventions offering hope for enhancing immune function in the elderly. Cutting-edge research un...
Recent studies highlight histone succinylation as a key epigenetic regulator of aging, with succinic acid supplementation showing promise for enhancing healthspan in mouse models and human trials. Eme...
